Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment

Citation:

A. Goel, Q. Chen, J. Chhatwal, and R. Aggarwal. 2018. “Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.” J Gastroenterol Hepatol, 33, 12, Pp. 2029-2036.

Copyright © 2019 The President and Fellows of Harvard College | Accessibility | Report Copyright Infringement